Focus on Biologics
Richard Mark Kirkner
Prices can be hard to swallow in this fastest-growing segment of the pharmaceutical market, but these approaches might help
Anonymized patient-level longitudinal data better supports formulary policy and coverage decisions, the authors say
Plan Watch
Frank Diamond
Cigna is just one insurer that has placed an emphasis on educating providers and patients about the benefits of full-term pregnancies
Legislation & Regulation
Richard Mark Kirkner
They want to make it impossible for insurers to change provider networks after the enrollment period
Medication Management
Thomas Reinke
PGX testing improves therapy oversight by predicting nonresponders
and identifying patients at risk for adverse drug responses
The Formulary Files
Krishna Rutvij Patel, PharmD
ACO Update
Peter Wehrwein
Savings generated by the CMS program are not impressive, but quality measures show improvement
Medical Device Monitor
Katherine T. Adams
Tomorrow’s Medicine
Thomas Morrow, MD
Cologuard is no substitute for colonoscopy for high-risk patients, but if this new tool means more people get screened, it could save lives
News & Commentary
Frank Diamond